|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-12-3
|
|
pubmed:abstractText |
ACTG A5164 demonstrated that early antiretroviral therapy (ART) in HIV-infected patients with acute opportunistic infections (OIs) reduced death and AIDS progression compared to ART initiation 1 month later. We project the life expectancies, costs, and incremental cost-effectiveness ratios (ICERs) of these strategies.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1528-4336
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
248-59
|
|
pubmed:dateRevised |
2011-10-21
|
|
pubmed:meshHeading |
pubmed-meshheading:21126955-AIDS-Related Opportunistic Infections,
pubmed-meshheading:21126955-Adult,
pubmed-meshheading:21126955-Anti-HIV Agents,
pubmed-meshheading:21126955-CD4 Lymphocyte Count,
pubmed-meshheading:21126955-Cohort Studies,
pubmed-meshheading:21126955-Computer Simulation,
pubmed-meshheading:21126955-Cost-Benefit Analysis,
pubmed-meshheading:21126955-Disease Progression,
pubmed-meshheading:21126955-Female,
pubmed-meshheading:21126955-HIV,
pubmed-meshheading:21126955-HIV Infections,
pubmed-meshheading:21126955-Humans,
pubmed-meshheading:21126955-Life Expectancy,
pubmed-meshheading:21126955-Male,
pubmed-meshheading:21126955-Models, Economic,
pubmed-meshheading:21126955-Models, Immunological,
pubmed-meshheading:21126955-Quality-Adjusted Life Years
|
|
pubmed:articleTitle |
Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164.
|
|
pubmed:affiliation |
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. psax@partners.org
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
